Advertisement

 

 

Emerging Roles of IL-33/ST2 Axis in Renal Diseases.

Emerging Roles of IL-33/ST2 Axis in Renal Diseases.
Author Information (click to view)

Chen WY, Li LC, Yang JL,


Chen WY, Li LC, Yang JL, (click to view)

Chen WY, Li LC, Yang JL,

Advertisement

International journal of molecular sciences 2017 04 0718(4) pii E783
Abstract

Renal diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD), have a great impact on health care systems worldwide. Similar to cardiovascular diseases, renal diseases are inflammatory diseases involving a variety of cytokines. Primary causes of renal injury include ischemia, uremic toxins, bacteremia, or nephrotoxicity. Inflammation represents an important component following kidney injury. Interleukin (IL)-33 is a member of the IL-1 cytokine family, which is widely expressed in epithelial barrier tissues and endothelial cells, and mediates both tissue inflammation and repair responses. IL-33 is released as a nuclear alarmin in response to tissue damage and triggers innate and adaptive immune responses by binding to its receptor, suppression of tumorigenicity 2 (ST2). Recent evidence from clinical and experimental animal studies indicates that the IL-33/ST2 axis is involved in the pathogenesis of CKD, renal graft injury, systemic lupus nephritis, and AKI. In this review, we discuss the pathological and tissue reparative roles of the IL-33/ST2 pathway in different types of renal diseases.

Submit a Comment

Your email address will not be published. Required fields are marked *

12 + three =

[ HIDE/SHOW ]